JP2021527102A5 - - Google Patents
Info
- Publication number
- JP2021527102A5 JP2021527102A5 JP2020569778A JP2020569778A JP2021527102A5 JP 2021527102 A5 JP2021527102 A5 JP 2021527102A5 JP 2020569778 A JP2020569778 A JP 2020569778A JP 2020569778 A JP2020569778 A JP 2020569778A JP 2021527102 A5 JP2021527102 A5 JP 2021527102A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pharmaceutically acceptable
- compound
- acceptable salt
- diseases
- Prior art date
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862685395P | 2018-06-15 | 2018-06-15 | |
| US62/685,395 | 2018-06-15 | ||
| US201962831867P | 2019-04-10 | 2019-04-10 | |
| US62/831,867 | 2019-04-10 | ||
| PCT/US2019/036877 WO2019241461A1 (en) | 2018-06-15 | 2019-06-13 | Tetrahydropyran-based thiodisaccharide mimics as galectin-3 inhibitors |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021527102A JP2021527102A (ja) | 2021-10-11 |
| JP2021527102A5 true JP2021527102A5 (https=) | 2022-01-14 |
| JPWO2019241461A5 JPWO2019241461A5 (https=) | 2022-01-14 |
| JP7190513B2 JP7190513B2 (ja) | 2022-12-15 |
Family
ID=67297250
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020569778A Active JP7190513B2 (ja) | 2018-06-15 | 2019-06-13 | ガレクチン－３抑制剤を模したテトラヒドロピラン系チオ二糖類 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11970511B2 (https=) |
| EP (1) | EP3807290B1 (https=) |
| JP (1) | JP7190513B2 (https=) |
| KR (1) | KR102802503B1 (https=) |
| CN (1) | CN112292386B (https=) |
| ES (1) | ES2912499T3 (https=) |
| WO (1) | WO2019241461A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113366007A (zh) * | 2018-10-15 | 2021-09-07 | 格莱克特生物技术公司 | 半乳糖凝集素的半乳糖苷抑制剂 |
| JP2022508719A (ja) * | 2018-10-15 | 2022-01-19 | ガレクト バイオテック エービー | ガレクチンのガラクトシド阻害剤のプロドラッグ |
| KR20230006547A (ko) * | 2020-05-05 | 2023-01-10 | 브리스톨-마이어스 스큅 컴퍼니 | 갈렉틴-3의 소분자 억제제 |
| EP4157833A1 (en) | 2020-05-28 | 2023-04-05 | Bristol-Myers Squibb Company | Galectin-3 inhibitors |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0401301D0 (sv) | 2004-05-21 | 2004-05-21 | Forskarpatent I Syd Ab | Novel 3-triazolyl-galactoside inhibitors of galectins |
| SE0401300D0 (sv) | 2004-05-21 | 2004-05-21 | Forskarpatent I Syd Ab | Novel Galactoside Inhibitors of Galectins |
| CN102439021B (zh) * | 2009-04-28 | 2015-09-02 | 格莱克特生物技术公司 | 半乳凝素的新型半乳糖苷抑制剂 |
| US20140243302A1 (en) | 2011-06-27 | 2014-08-28 | Merck Sharp & Dohme Corporation | Bridged bicyclic compounds for the treatment of bacterial infections |
| US9021050B2 (en) | 2012-08-31 | 2015-04-28 | Yume, Inc. | Network service system and method with off-heap caching |
| US8828971B2 (en) | 2012-10-10 | 2014-09-09 | Galectin Therapeutics, Inc. | Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders |
| JP2015535233A (ja) * | 2012-10-31 | 2015-12-10 | ガレクト・バイオテック・エイビイ | ガレクチン−３のガラクトシド阻害剤及び肺線維症のためのその使用 |
| WO2014078655A1 (en) | 2012-11-15 | 2014-05-22 | Tufts University | Methods, compositions and kits for treating, modulating, or preventing ocular angiogenesis or fibrosis in a subject using a galectin protein inhibitor |
| EP3415522A1 (en) * | 2014-07-09 | 2018-12-19 | Galecto Biotech AB | Novel hybrid galactoside inhibitor of galectins |
| JP6904906B2 (ja) | 2015-01-30 | 2021-07-21 | ガレクト・バイオテック・エイビイ | ガレクチンの新規なガラクトシド阻害剤 |
| ES2921500T3 (es) | 2015-11-09 | 2022-08-26 | Galecto Biotech Ab | 1,1'-sulfanodiil-di-beta-d-galactopiranósidos como inhibidores de galectinas |
| JP6844991B2 (ja) | 2015-11-10 | 2021-03-17 | サンコ テキスタイル イスレットメレリ サン ベ ティク エーエスＳａｎｋｏ Ｔｅｋｓｔｉｌ Ｉｓｌｅｔｍｅｌｅｒｉ Ｓａｎ． Ｖｅ Ｔｉｃ． Ａ．Ｓ． | ジッパーを有する伸縮性衣類の製法 |
-
2019
- 2019-06-13 JP JP2020569778A patent/JP7190513B2/ja active Active
- 2019-06-13 CN CN201980039715.9A patent/CN112292386B/zh active Active
- 2019-06-13 WO PCT/US2019/036877 patent/WO2019241461A1/en not_active Ceased
- 2019-06-13 EP EP19740100.3A patent/EP3807290B1/en active Active
- 2019-06-13 ES ES19740100T patent/ES2912499T3/es active Active
- 2019-06-13 KR KR1020217000905A patent/KR102802503B1/ko active Active
- 2019-06-13 US US17/251,964 patent/US11970511B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021527102A5 (https=) | ||
| JP2020510664A5 (https=) | ||
| JP2016517432A5 (https=) | ||
| JP2005531609A5 (https=) | ||
| JP2019526582A5 (https=) | ||
| JP2005509024A5 (https=) | ||
| CN110582489A (zh) | Rho相关蛋白激酶抑制剂、包含其的药物组合物及其制备方法和用途 | |
| JP2012504141A5 (https=) | ||
| JP2016540017A5 (https=) | ||
| JP2019503385A5 (https=) | ||
| KR20090042808A (ko) | 씨알티에이치2 길항제 활성을 갖는 화합물 | |
| JP2011502982A5 (https=) | ||
| JP2019529359A5 (https=) | ||
| JP2007508238A5 (https=) | ||
| JPWO2019126085A5 (https=) | ||
| JP2017536342A5 (https=) | ||
| CA2617991A1 (en) | N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof | |
| JPWO2020210308A5 (https=) | ||
| JP2017522350A5 (https=) | ||
| JP2023062064A5 (https=) | ||
| JPWO2019241461A5 (https=) | ||
| RU2017145086A (ru) | Производные 3-(6-хлор-3-оксо-3,4-дигидро-(2h)-1,4-бензоксазин-4-ил)пропионовой кислоты и их применение в качестве ингибиторов kmo | |
| JPWO2020198266A5 (https=) | ||
| JPWO2021062245A5 (https=) | ||
| JP2020520388A5 (https=) |